Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : STOCKS WITH ATTITUDE TEAM - FA/TA AND EVERYTHING ELSE -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (1579)	1/13/1998 10:17:00 PM
From: Amigo Mike	Respond to of 2377

Hi Sergio, I see that you are the only one who picked up on my short term pick of CYPB. I don't post many to the thread .... but I feel pretty confident when I mention one like CYPB. I believe there is still time to get in on this one. I think it will definitely rise from here. Huge volume for the last two days + plenty of insider buying the last few months. FDA approval for PROSORBA should come quickly as it is already approved for another use. The Arthritis market is an estimated $2 BILLION MARKET !!! CYPB's process is unique and appears to be affective in treating arthritis. With the population aging, there are bound to be more and more cases as time goes on. This one is gonna go ! Mike